Cellular and Molecular Mechanisms of Neuroinflammation in Drug-Resistant Epilepsy-Reference-Cited by-同舟云学术

Cellular and Molecular Mechanisms of Neuroinflammation in Drug-Resistant Epilepsy

Published:2023 Issue: Volume: Page:131-156
ISSN:
Container-title:Pharmacoresistance in Epilepsy
language:
Short-container-title:

Author:

Mercado-Gómez Octavio Fabián,Arriaga-Ávila Virginia Selene,Vega-García Angélica,Sánchez-Hernández Josué,Jiménez Adriana,Organista-Juárez Diana,Guzmán-Ruiz Mara A.,Guevara-Guzmán Rosalinda

Publisher

Springer International Publishing

Link

https://link.springer.com/content/pdf/10.1007/978-3-031-36526-3_8

Reference165 articles.

1. Aguiar CC, Almeida AB, Araujo PV, de Abreu RN, Chaves EM, do Vale OC, Macedo DS, Woods DJ, Fonteles MM, Vasconcelos SM. Oxidative stress and epilepsy: literature review. Oxidative Med Cell Longev. 2012;2012:795259. https://doi.org/10.1155/2012/795259.

2. Alajangi HK, Kaur M, Sharma A, Rana S, Thakur S, Chatterjee M, Singla N, Jaiswal PK, Singh G, Barnwal RP. Blood-brain barrier: emerging trends on transport models and new-age strategies for therapeutics intervention against neurological disorders. Mol Brain. 2022;15(1):49. https://doi.org/10.1186/s13041-022-00937-4.

3. Almeida C, Pongilio RP, Movio MI, Higa GSV, Resende RR, Jiang J, Kinjo ER, Kihara AH. Distinct cell-specific roles of NOX2 and MyD88 in epileptogenesis. Front Cell Dev Biol. 2022;10:926776. https://doi.org/10.3389/fcell.2022.926776.

4. Alyu F, Dikmen M. Inflammatory aspects of epileptogenesis: contribution of molecular inflammatory mechanisms. Acta Neuropsychiatr. 2017;29(1):1–16. https://doi.org/10.1017/neu.2016.47.

5. Archie SR, Al Shoyaib A, Cucullo L. Blood-brain barrier dysfunction in CNS disorders and putative therapeutic targets: an overview. Pharmaceutics. 2021;13(11):1779. https://doi.org/10.3390/pharmaceutics13111779.